Incyte INCB 39110-209 Ph2 Itacitinib PMF, PET-MF and PV-MF - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn about the effects of the drug itacitinib taken with ruxolitinib or itacitinib alone.
Who Can Participate in the Study?
- Have a confirmed diagnosis of PMF, PPV-MF, or PET-MF
- Have a bone marrow biopsy specimen available or willingness to undergo a bone marrow biopsy
- Have a life expectancy of at least 24 weeks
- Have an ECOG performance status of 0, 1, or 2.
What is Involved?
If you choose to join this study, you will:
- Get blood tests, MRIs, plasma lab tests as well as spleen/liver assessments
- Have Lipid panel test (measuring how much fat you have in your blood)
- Have multiple discussions about your current and past health